Skip to content

Clinical trials

Terminated Congenital Abnormalities trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Status: Terminated Country / region: United States Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20035
20046
20057
200610
20074
20088
20098
20107
20114
20123
20133
20145
20152
20161
20172
20202
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated89

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center10
Masonic Cancer Center, University of Minnesota8
National Cancer Institute (NCI)8
City of Hope Medical Center6
Roswell Park Cancer Institute5
OHSU Knight Cancer Institute4
Vanderbilt-Ingram Cancer Center4
Rutgers, The State University of New Jersey3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Barbara Ann Karmanos Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities89
Leukemia, Myeloid, Acute66
Leukemia42
Blast Crisis37
Precursor Cell Lymphoblastic Leukemia-Lymphoma36
Myelodysplastic Syndromes32
Leukemia, Lymphocytic, Chronic, B-Cell31
Leukemia, Myeloid, Accelerated Phase31
Lymphoma, Follicular29
Lymphoma, Large B-Cell, Diffuse29

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.